GlycoMimetics Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML

Evaluating previously untreated newly diagnosed adults with acute myeloid leukemia (AML) who are fit for intensive chemotherapySecond initiation among three late-stage uproleselan clinical trials ROCKVILLE, Md.–(BUSINESS WIRE)–Apr. 23, 2019– GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in a Phase 3 clinical trial being conducted under the auspices of a Cooperative Research and Development Agreement […]

PressComm PR Client Rachel King, CoFounder and CEO, GlycoMimetics Inc. Featured on PharmaVOICE Podcast

King-Rachel-PVcom-FeaturedImage630x315-560x315

Rachel King has charted a unique career — from consultant to VC to startup to now CEO — and is leading a pioneering company in the use of glycobiology technology. Click here to listen to the podcast via Pharmavoice.com”

Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that Co-Founder and President Caroline Popper, M.D., will speak at the 10th Annual Next Generation Dx Summit on August 22 at 5 pm ET at the Grand Hyatt Washington in Washington, DC. In the era of precision medicine, it’s more important […]

University of Maryland (UM) Ventures Launches New Website

University of Maryland Ventures launches new website

The BioBuzz on… UM Ventures and Jim Hughes

A year ago, James L. Hughes, M.B.A., vice president and chief enterprise and economic development officer at University of Maryland, Baltimore (UMB), was named director of University of Maryland Ventures (UM Ventures), the ambitious joint research commercialization effort of UMB and University of Maryland, College Park (UMCP), and a central part of the MPowering the State initiative. […]

BHI’s Rich Bendis Contributed to Special Report from White House Lab-to-Market Inter-Agency Summit

BHI CEO Rich Bendis recently served as an expert panelist contributing to a special report from the “White House Lab-to-Market Inter-Agency Summit.” Panelists examined the U.S. federal government’s investment in drug R&D and the resulting private sector commercialization. According to the Summit report: Federal research has done exceedingly well at accomplishing its original intent, which […]

Rachel King of GlycoMimetics Named to 2013 PharmaVOICE 100

On August 1, 2013, PharmaVOICE included Rachel King, CEO of GlycoMimetics, among the 2013 PharmaVOICE 100 list. Established nine years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. These individuals illustrate what it means to think bigger, do more, and lead […]

Tech Council of Maryland Honors Dr. James Barrett with Lifetime Achievement Award

The Tech Council of Maryland (TCM) awarded its Third Annual Lifetime Achievement Award to GlycoMimetics (client) Chairman of the Board James Barrett, Ph.D. on April 18, 2013 at the Bethesda North Marriott Hotel & Conference Center. Dr. Barrett was also a former chairman of the board of MedImmune. TCM bestows its Lifetime Achievement Award each […]

BioHealth Innovation, Inc. (#client) Co-Sponsors BioBuzz Event

On March 20, 2013, BioHealth Innovation, Inc. (BHI), #client, co-sponsored a BioBuzz event with the JHU Center for Biotechnology Education. This monthly networking event and social gathering brings together biotech professionals in Maryland with the goal of creating a stronger community within the industry. “Last month we had a great turnout with around 120 people, […]

PressComm PR, Ainsley & Co. Partner to Produce Video for Novavax

PressComm PR recently teamed with Ainsley & Co., a strategic marketing and advertising firm, to develop an online video for Montgomery County-based vaccine company, Novavax. In this new video, Novavax CEO Stanley Erck speaks on the different processes Novavax scientists are working on, and the overall momentum of the company. Through the progression of planning, […]

PressComm

Archive | Clients